Ri i IfiRespiratory virus Infections Laboratory testingLaboratory … · Rh di i 8 Ki’...
Transcript of Ri i IfiRespiratory virus Infections Laboratory testingLaboratory … · Rh di i 8 Ki’...
R i i I f iRespiratory virus Infections&&
Laboratory testingLaboratory testing
The Common Cold
The common cold is a viral infection of the upper respiratory tract Usually last approximately 7 daysrespiratory tract Usually last approximately 7 days
Common Cold Syndrome includes rhinitis, tonsilitis,Common Cold Syndrome includes rhinitis, tonsilitis, pharyngitis, laryngitis (including croup), pharyngo-laryngitis etc. Sometimes Influenza (the flu) and sinusitis are characterized as a common coldsinusitis are characterized as a common cold syndrome
Season of the year, age, and prior exposure are y g p pimportant factors in the type of virus causing the infection and the type of symptoms that may occur
RISK FACTOR FOR MORE SEVERRISK FACTOR FOR MORE SEVER COMMON COLD
LOW NEUTRALIZING AbLOW NEUTRALIZING AbCHRONIC LUNG DISEASEEXTREMES AGEASTHMA
ALLERGYIg EIg ECYTOKINE PRODUCTION
I F N -gammaI L-5
Common Cold Viruses% COLD% COLDSEROTYPESEROTYPEVIRUSESVIRUSES % COLD% COLDSEROTYPESEROTYPEVIRUSESVIRUSES
60+100RHINOVIRUS
152CORONAVIRUS
< 103INFLUENZA
< 104PARA INFLUENZA
<102R S V <102R S V
< 1047ADENOVIRUS
< 10+40ENTROVIRUS
Variables used to distinguish viral fromVariables used to distinguish viral from bacterial pneumonia
CoronavirusCoronavirus
Coronavirus classification
• Order Nidovirales• Order Nidovirales• Family Coronaviridae• Genus Coronavirus• Genus Coronavirus• Non-segmented (+) ssRNA virus•There are 4 major groups within There are 4 major groups within coronavirus:
group 1- HCoV-229E (6 species)g p pgroup 2- HCoV-OC43 (7 species)group 3- Avian CoV (1 specie)SARS- CoV (1 specie)- responsible
for SARS epidemiology in 2003
Environmental stabilityEnvironmental stabilityEnvironmental stabilityEnvironmental stability
Viable virus on surfaces after 24 hrs
Easily inactivated by…H tHeatDryingLi id l tLipid solvents Oxidizing agentsDetergentsDetergentsUV radiation
Coronavirus proteins with immunoevasive properties
protein Virus source function
NSP1 SARS HKU4 a)Suppresses host protein expression throughNSP1 SARS,HKU4,HKU9
a)Suppresses host protein expression through direct inhibition of translation or by promoting
degradation of host mRNA including IFN-mRNAb)Inhibits IFN induction and signaling
NSP3(PLP) SARS,NL63 Blocks IRF3 activation and NFkB signaling
NSP3(ADRP) SARS 229E )I t f ith IFN i d d i l ti itNSP3(ADRP) SARS,229E a)Interfere with IFN induced viral activityb)Enhances host proinflammatory cytokine
expression
ORF 3b i SARS I hibi IFN h i d i liORF 3b protein SARS Inhibits IFN synthesis and signaling
ORF 6 SARS Inhibits STAT1 nuclear translocation
N SARS Inhibits IFN inductionInterfere with 2’,5’ OAS RNase L activity
M SARS Inhibits IRF3 activation
SARS pathogenesisSARS pathogenesis3 phases :
1. Viral replication2. Immune hyperactivity3. Pulmonary destruction
Pathology in the lung :Diffuse alveolar damage Epithelial cell proliferation p pIncrease of MQ
Multinucleate giant-cell have been associated with
putative syncytium like formation that is characteristic of
many coronaviruses infections
Symptoms y p• Clinical course:
short incubation period (6 days)time period from exposure to onset of symptoms ranging
from 2 to 16 daysintensive care usually required about 10 days after onsetintensive care usually required about 10 days after onset
of symptoms•There are generally 3 phases:
k 1 ld lik t f l i hill dweek 1: cold like symptoms,fever, myalgia, chill and a sore throat
week 2, recurrence of fever. Onset of diarrhea, and d t tioxygen desaturation
only 20% of patients reach this phase, requires ventilatory support
The fatality rate is about 10% upon infection
Risk factorsRisk factorsAgeHigh peak LDHg pHigh absolute neutrophil count
SARS-CoV Laboratory Testing: Specimens for PCRSpecimens for PCR
Lower respiratory tract specimensSputum, broncheoalveolar lavage, tracheal aspirate
Upper respiratory tract specimensNasopharyngeal aspirate/washp y g pNasopharyngeal/oropharyngeal swab
Place in dry sterile containeryDacron or rayon with plastic shaft
Blood5-10ml in EDTA tube (Purple top)5 10ml in EDTA tube (Purple top)
Stool10 - 50cc in stool cup or urine container, no preservatives
14
Store all specimens at 4oC prior to shipping
SARS-CoV Laboratory TestingSARS CoV Laboratory Testing
Real-time PCR
Respiratory specimens
SerologySerologyELISA for total antibody (IgG, IgM, and IgA)Considered the “Gold Standard”
Viral CultureTo rule-out other respiratory virusesNOT for SARS-CoV
SARS-CoV Laboratory Testing:
Real-time RT-PCRSensitivity: 1-10 copies in the reaction mixtureSensitivity: 1 10 copies in the reaction mixtureMultiple samples and specimen types can increase
sensitivity
Highly specific for SARS-CoV, but <50% sensitive during 1st week of infectionduring 1st week of infection
Low viral titers early in infection
Potential for false negatives(Poor samples, degradation during transport, low titers)
False positives are always a concern
SARS-CoV Laboratory Testing: S i f S lSpecimens for Serology
Acute and convalescent seraAcute and convalescent sera
approx. 30% positive within 6-10 days post-onset
Convalescent serum----Collect >28 days post-onset
Most patients positive at 2 weeksMost patients positive at 2 weeks
6-14 days before antibody detectable
Serology cannot be considered negative until >28 days
post onset
Biosafety in the LaboratoryBiosafety in the Laboratory
Untreated specimenspBSL-2 facilities using BSL-3 practices
Biosafety cabinet (BSC)
Centrifuge using sealed rotors or sample cups
Perform risk assessmentMay want to refer to another laboratory
Viral culture of suspect SARS specimens should be performed in BSL-3 facilityperformed in BSL 3 facility
ADENOVIRUSESADENOVIRUSES
Adenovirus Genome
Late genesE1 E3
Late genes
E2 E4
36 kb linear ds DNA
Early genes for host and viral transcription y g pcontrol, viral DNA replication
Late genes for virion structureLate genes for virion structure
Adenovirus Genome
Late genesE1 E3
Late genes
E2 E4
36 kb linear ds DNA
Earl genes for host and iral transcription control iralEarly genes for host and viral transcription control, viral DNA replication
Late genes for virion structureg
CLINICAL SYNDROMES
A. Respiratory diseases: p y
B. Eye infections:
C. Gastrointestinal disease
D. Other diseases:
E. Adenoviral infections of the immune compromised host
Respiratory diseases:Respiratory diseases:
The most important etiological association of adenoviruses is with the respiratory diseases.
They are responsible for 5% of acute respiratory diseases in:young children and much less in adults.
Respiratory diseases:Respiratory diseases:Four different syndromes of respiratory infection haveFour different syndromes of respiratory infection have been linked to Adenoviruses.
Acute febrile pharyngitis: most commonly seen in infants and young children,symptoms include cough, stuffy nose, fever and sore throat.
Pharyngo conjunctival fever:Pharyngo conjunctival fever:symptoms are similar to those of acute febrile pharyngitis but
conjunctivitis is also present. It tends to occur in outbreaks such as at children's summer camps
(swimming pool conjunctivitis)(swimming pool conjunctivitis).
Respiratory diseases:p y
Acute respiratory disease:is characterized by pharyngitis, fever, cough and
malaisemalaise. It occurs in an epidemic form among young
recruits under conditions of fatigue and overcrowdingovercrowding
Pneumonia: a complication of acute prespiratory disease in both children and adults.
Cli i l t tiClinical presentations
Clinical Syndromesy1. Pharyngitis 1, 2, 3, 5, 72 Pharyngoconjunctival fever 3 72. Pharyngoconjunctival fever 3, 7 3. Acute respiratory disease of recruits 4, 7, 14, 21 4. Pneumonia 1, 2, 3, 7 5. Follicular conjunctivitis 3, 4, 116. Epidemic keratoconjunctivitis 8, 19, 37 7. Pertussis-like syndrome 5 y8. Acute haemorrhaghic cystitis 11, 21 9. Acute infantile gastroenteritis 40, 41 10 Intussusception 1 2 510.Intussusception 1, 2, 511.Severe disease in AIDS and other immunocompromized patients 5, 34, 3512. Meningitis 3, 7
Adenoviral infections of theAdenoviral infections of the immune compromised host
The most common clinical manifestations are:
pneumoniapneumonia
hepatitis p
gastroenteritis
Laboratory Diagnosisy g
Direct detection:Direct detection:
I l tiIsolation
Serology
Laboratory Diagnosis
Direct detection:
Virus particle by EM can be detected by direct examination
Detection of adenoviral antigens by ELISA.Enteric Adenoviruses
D t ti f d i l NA b PCR b d f di iDetection of adenoviral NA by PCR: can be used for diagnosis of Adenovirus infections in tissue samples or body fluids.
Laboratory DiagnosisLaboratory Diagnosis
I l tiIsolation:
Adenovirus may be isolated from most body fluids and ti b th t b i f dsecretions; eye swabs, throat swabs, urine, faeces, and
CSF. Human embryonic kidney cells Hep-2 cells Primary monkey kidney cells 293 cellsPrimary monkey kidney cells 293 cells
CPE includes rounding, clustering of cells with CPE includes rounding, clustering of cells with refractilerefractileintranuclearintranuclear inclusion bodies inclusion bodies
Isolation is much more difficult from the stool or rectal swabs
Laboratory Diagnosisy g
SerologySerologyHaemagglutination inhibition Neutralization testsNeutralization tests
can be used to detect specific antibodies following Adenovirus infection.
CytomegalovirusCytomegalovirus
ClassificationSubfamily Growth &
CytopathologyLatent
infectionsGenus Official
name (herpesv
irus)
Common name
Alphaherpesvirinae Short, cytolytic Neurons Simplexvirus 12
HSV-1HSV-2
Vaicellvirus 3 VZV
B t h i i L Gl d C t l i 5 CMVBetaherpesvirinae Long, cytomegalic
Glands, kidneys
Cytomegalovirus 5 CMV
Long, lymphoproliferati
Lymphoid tissue
Roseolovirus 67
HHV-6HHV-7
ve
Gammaherpesvirinae Long, lymphoproliferative
Lymphoid tissue
Lymphocryptovirus 4 EBV
Rh di i 8 K i’
Herpesviridae 37
Rhadinovirus 8 Kaposi’ sarcoma virus
Pathogenesis & Pathology inNormal hosts
CMV transmission: person to person by close contactCMV transmission: person-to-person by close contact
Incubation period 4-8 weeks
Infectious mononucleosis-like
Most infections are subclinicalMost infections are subclinical
Lifelong latent infections
Virus shed from pharynx & urine for months to years
Prolonged kidney and salivary gland infections
Cell-mediated immunity is depressed
Pathogenesis & Pathology inimmunosupressed hosts
Primary CMV infections in immunosupressedPrimary CMV infections in immunosupressed
hosts are more severe
Viral excretion is increased & prolonged
Infection is disseminated
Pneumonia is most commonPneumonia is most common
Ductal epithelial cells are usually infected
Laboratory Diagnosis (1)Laboratory Diagnosis (1)Direct detection
In this assay, leukocytes are separated from other bloodelements, spotted onto a microscope slide, and stainedusing a monoclonal antibody to pp65 the CMV lowerusing a monoclonal antibody to pp65, the CMV lowermatrix phosphoprotein
The pp65 CMV antigenaemia test is now routinely usedpp g yfor the rapid diagnosis of CMV infection inimmunocompromised patients.
C f C A i d i b hPCR for CMV-DNA is used in some centers but theremay be problems with interpretation.
CMV pp65 antigenaemia testCMV pp65 antigenaemia test
(Virology Laboratory, New-Yale Haven Hospital)
Laboratory Diagnosis (2)y g ( )Virus Isolation
conventional cell culture is regarded as gold standard butconventional cell culture is regarded as gold standard butrequires up to 4 weeks for result.
More useful are rapid culture methods such as the DEAFF(Detection of early antigen fluorescent foci) testwhich can provide a result in 24-48 hours.
Cultures of blood are more helpful diagnostically, becausepositive blood cultures are virtually never found in
t ti i i d i di id lasymptomatic, non immunocompromised individuals.
Cytopathic Effect of CMVCytopathic Effect of CMV
(Courtesy of Linda Stannard, University of Cape Town, S.A.)
DEAFF test for CMV
(Virology Laboratory, New-Yale Haven Hospital)
Laboratory Diagnosis (3)y g ( )Serology:
the presence of CMV IgG antibody indicates past infection. The detection of IgM is indicative of primary infection
C tomegalo ir s serolog is of less al e for the diagnosis ofCytomegalovirus serology is of less value for the diagnosis ofinfections in immunocompromised patients than direct tests forthe virus.
is useful, however, for the diagnosis of CMV infection in thenormal host and for defining CMV immune status, for example inblood donors or for transplant donors and recipients.
EIA is more sensitive than the complement fixation test,which was widely used in the past.
CMV avidity assays
Specimens for Laboratory Diagnosis
Site for virus culture Serology Urine Saliva Blood Tissue affected IgG IgM Neonates + + - - - + Adults + - + - + +Adults + - + - + + Pregnant women - - - - + + Immunocompromised + + + + + -
Cytomegalovirusy g
Cytomegalovirus in the Normal Host:y g
a mononucleosis-like illness. the heterophile antibody t t i titest is negative.
It should be noted that acute EBV infection can also yield a false positive finding in the CMV IgM test.a false positive finding in the CMV IgM test.
In patients with CMV mononucleosis, CMV is regularly detected in the urine by culture, and often in the blood by
lt th 65 ti i PCRculture, the pp65 antigenemia, or PCR
Cytomegalovirusy gCytomegalovirus in the Immunocompromised Host:
important cause of opportunistic infection in patients who havereceived either solid organ or hematopoietic stem celltransplants and AIDStransplants and AIDS.
quantitative test performed on blood. PCR is the mostsensitive test.
The hybrid capture assay and the pp65 antigenemia assaybecome positive several days to 1 week after PCR andoccasionally fail to detect CMV antigenemia before the onset ofsymptoms.
Culture is the least sensitive, and often the last test to becomepositive.positive.
BocavirusBocavirus
VIRUS STRUCTURE
Fam
ily Parvoviridae
Sub
fam
ily Parvovirinae
Gen
us Boca virus
Li DNA f b 5 5kb i i• Linear, ssDNA genome of about 5.5kb in size• Non-enveloped capsid of icosahedral symmetry and
diameter of ~25 nm• Proteins Non-structural NS1
NP1(nuclear phosphoprotein)Structural VP1Structural VP1
Introduction
4 species of human bocavirus :4 species of human bocavirus :Respiratory pathogen
Stool pathogen
HBoV1 HBoV2
Important
HBoV3
Importantcause of LRTI HBoV4
RISK FACTORSproduce a long-lasting , high-avidity IgG antibody response
l k f t ti B ll i it i ht i th i k f HB Vlack of protecting B-cell immunity might increase the risk of HBoV
infection
Risk factors for severe HBoV1-associated illness have been
considered to be similar to those for common respiratory viral
infections:
cardiac disease (congenital heart lesions or heart failure)pulmonary disease (asthma or chronic obstructive pulmonary disease)pulmonary disease (asthma or chronic obstructive pulmonary disease)Prematurity with chronic lung disease ImmunosuppressionYoung age
maternal smokingmaternal smokingwinter birth timeAsthma predisposition
Signs and symptoms S g s a d sy p o srhinitis, pharyngitis , cough, wheezing, pneumonia, acute otitis media, fever, nausea, p , , , ,vomiting, and diarrhea
Diagnostic approach Quantitative PCRSerologySerology
RhinovirusRhinovirus
I t d tiIntroduction y Picornaviridae s Entrovirus s A
Fam
il
Gen
u
Spe
cie B
C
S
URTI Otitis media Si itiSinusitis Chronic pulmonary disease Asthma development Severe bronchiolitis in infants and childrenFatal pneumonia in elderly and immunocompromised adults
Rhinovirus
Belong to the picornavirus familySmall 20-30nmIcosahedral symmetryNon enveloped-acid-labileSi l t d d iti RNASingle stranded positive sense RNAat least 100 serotypes are known
ssRNA , 7.2 Kb Single gene : 11 proteins , cleaved by proteasesVP1,2,3,4 : viral capsid VP1,2,3 : antigenic diversity
60 copies of each made an p g y
VP4 : anchors the RNA core to the capsidNS : assembly and replication
icosahedral structure
Functions of Viral ProteinsDerived from one polyprotein precursor
Processed by post-translational cleaving
Structural proteinsStructural proteinsresponsible for host tropismsprotection of genome
ti i itantigenicityNon-structural proteins
proteasesRNA polymeraseinhibitors of normal host cell functions
Canyon in VP1 : site of attachment to cell surface receptors :Major group :ICAM-1 , Heparan sulfatej g p , pMinor Group :LDLR
Di i i f th i i l 99 t i i t 3 iDivision of the original 99 strains into 3 species:HRV-A (74 serotypes)HRV-B (25 serotypes)HRV B (25 serotypes)HRV-c (50 serotypes)
Each serotype (>115) is distinctnot cross-reactivelittl t tilittle cross-protection
RhinovirusRhinovirusRhinovirus infections are chiefly limited to the upper
respiratory tract but may include otitis media and sinusitissinusitis.
Rhinovirus plays a role in exacerbations of asthma, cystic fibrosis, chronic bronchitis, and serious lower
i ill i i f ld l drespiratory tract illness in infants, elderly persons, and patients who are immunocompromised
Although infections occur year-round, the greatest incidence is in the fall and spring.
Of persons exposed to the virus, 70-80% have symptomatic disease.symptomatic disease.
PathophysiologyPathophysiology
Rhinoviruses are transmitted to susceptible individuals by :direct contact
aerosol particles
infecting both ciliated areas of the nose and nonciliated areas of the nasopharynx through receptors, most frequently ICAM-1 (found in high quantities in the posterior nasopharynx)in high quantities in the posterior nasopharynx).
Few cells are actually infected by the virus, and the infection involves only a small portion of the epitheliumonly a small portion of the epithelium.
Pathophysiologylocalized infections of the nose
symptoms occur 2 to 4 days after exposure and last about one week There is no feverone week. There is no fever.
The virus has a limited temperature range in which it can p ggrow (33-35°C) and cannot tolerate an acidic environment.Thus finding the virus outside of the nasopharynx is unlikelyThus, finding the virus outside of the nasopharynx is unlikely because of the acidic environment of the stomach and the temperature elevation in both the lower respiratory and gastrointestinal tracts. g
LABORATORY DIAGNOSISDirect detection of rhinovirus antigen: an ELISA has been
developed for the detection of rhinovirus antigen in nasal washings.
Culture: Nasal washing is the best clinical specimen for recovering the virus.
Rhinoviruses grow ONLY IN in vitro on:Rhinoviruses grow ONLY IN in vitro on:Cells of primate origin,Human diploid fibroblast cells
The virus CPE, which consists of the rounding of cells similar to that induced by enteroviruses should appear within 8 d f i l tidays of inoculation.
The identity can be confirmed by acid lability tests. (pH3) Serology:Serologic testing to document rhinovirus infection is
i lnot practical.virus neutralization tests remain the best method.
Normal Cells Infected Cells
Laboratory testingLaboratory testing
Respiratory Viral Infectionsp yA. Culture:The influenza and parainfluenza viruses replicate best in primary monkey kidney cells, although continuous cell lines (e.g., Madin-Darby canine kidney) can be used for influenza and LLC-MK2 for parainfluenza
without producing CPE and hemadsorption with guinea pig erythrocytes is used for detection (24 hours)pig erythrocytes is used for detection (24 hours)
RSV replicates optimally in HEp-2 cells very labileRSV replicates optimally in HEp 2 cells. very labile.delayed transport result in failure to isolate RSV.
Respiratory Viral InfectionsAdenoviruses replicate optimally in human embryonic kidney cells.
p y
Rhinoviruses replicate only in human diploid fibroblast cells. Incubation at 33°C to 34°C.human metapneumovirus grown in monkey kidneyhuman metapneumovirus grown in monkey kidney cells (e.g., LLC-MK2), but growth is slow and clearly less sensitive than detection by molecular methods.SARS replicates in Vero and other monkey kidney cells, including fetal rhesus monkey kidney cells.R tl th f lt i i t iRecently, the process of culturing respiratory viruses has been simplified by the development of mixed cell culture systems
Respiratory Viral InfectionsB. Antigen Detection:be used to achieve rapid diagnosis of RSV, influenza, parainfluenza and adenovirus respiratory tract infection
p y
parainfluenza, and adenovirus respiratory tract infection.Viral antigens are visualized by FA staining of respiratory epithelial cells.pnasopharyngeal aspirate, wash, or swab, Tracheal aspirate and bronchoalveolar lavage specimens.Aspirates and washes provide a higher cellular yield and have higher viral titers than swabs.Rhinoviruses and coronaviruses are not detected byRhinoviruses and coronaviruses are not detected by antigen detection methods because of antigenic diversity and lack of availability of appropriate antibodies.
Respiratory Viral InfectionsC. Nucleic Acid Amplification:The advantages of these assays are increased
p y
sensitivity compared with conventional methods and the ability through multiplex methods to detect multiple viruses in the same sampleviruses in the same sample.nucleic acid amplification can detect viruses such as HMPV, coronaviruses, and human bocavirus that are difficult or impossible to detect by other methods.A advantage is that nucleic acid amplification facilitates the detection of respiratory viruses from non respiratorythe detection of respiratory viruses from non respiratory sites.
Other Possible Diarrhoeal Viruses
CoronavirusesRNA viruses with a crown-like appearance
Not convincing associated with gastroenteritis at present
Small Round Virusesll i lik i l i h h f 22 28 i dismall virus-like particles with a smooth surface, 22-28nm in diameter
may possibly be parvoviruses, enteroviruses, or cubic bacteriophages
occasionally seen in the faeces of endemic or epidemic cases ofoccasionally seen in the faeces of endemic or epidemic cases of gastroenteritis